Canadian Pharmaceuticals & Biotech High Growth Potential Companies

Sernova Biotherapeutics

Market Cap: CA$59.1m

Operates as a clinical-stage biotechnology company in Canada.

Curaleaf Holdings

Market Cap: CA$923.9m

Produces and distributes cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$1.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Knight Therapeutics

Market Cap: CA$572.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Medexus Pharmaceuticals

Market Cap: CA$92.9m

Operates as a pharmaceutical company in Canada and the United States.

Theratechnologies

Market Cap: CA$164.6m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Aurora Cannabis

Market Cap: CA$418.2m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Rakovina Therapeutics

Market Cap: CA$7.0m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Medicenna Therapeutics

Market Cap: CA$85.0m

An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.

Cardiol Therapeutics

Market Cap: CA$141.3m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.